Literature DB >> 12562028

Adherence to antiretroviral therapy: where are we, and where do we go from here?

Albert W Wu1, Adriana Ammassari, Andrea Antinori.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12562028     DOI： 10.1097/00126334-200212153-00001

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  6 in total

1.  Associations among correlates of schedule adherence to antiretroviral therapy (ART): a path analysis of a sample of crack cocaine using sexually active African-Americans with HIV infection.

Authors:  J S Atkinson; L Nilsson Schönnesson; M L Williams; S C Timpson
Journal:  AIDS Care       Date:  2008-02

2.  Is the quality of the patient-provider relationship associated with better adherence and health outcomes for patients with HIV?

Authors:  Mary Catherine Beach; Jeanne Keruly; Richard D Moore
Journal:  J Gen Intern Med       Date:  2006-06       Impact factor: 5.128

Review 3.  Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS.

Authors:  S Rueda; L Y Park-Wyllie; A M Bayoumi; A M Tynan; T A Antoniou; S B Rourke; R H Glazier
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

4.  Impact of a brief patient and provider intervention to improve the quality of communication about medication adherence among HIV patients.

Authors:  Mary Catherine Beach; Debra L Roter; Somnath Saha; P Todd Korthuis; Susan Eggly; Jonathan Cohn; Victoria Sharp; Richard D Moore; Ira B Wilson
Journal:  Patient Educ Couns       Date:  2015-05-21

5.  Effects of Minimal Versus Intensive Intervention to Enhance Motivational Interviewing in HIV Care.

Authors:  Mary Catherine Beach; M Barton Laws; Gary Rose; Debra Roter; Yoojin Lee; Geetanjali Chander; Tanita Woodson; Richard D Moore; William Rogers; Ira B Wilson
Journal:  AIDS Behav       Date:  2018-01

6.  Measuring adherence to antiretroviral therapy in northern Tanzania: feasibility and acceptability of the Medication Event Monitoring System.

Authors:  Ramsey A Lyimo; Jossy van den Boogaard; Elizabeth Msoka; Harm J Hospers; Andre van der Ven; Declare Mushi; Marijn de Bruin
Journal:  BMC Public Health       Date:  2011-02-09       Impact factor: 3.295
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.